Induction Failure in de novo Acute Myelogenous Leukemia is Associated with Expression of High Levels o CD34 Antigen by the Leukemic Blasts

References

• Schmitt C., Eaves C.J., Lansdorp P.M. Expression of CD34 on human B cell precursors. Clinical and Experimental Immunology 1991; 85: 168–173
   PubMed Web of Science ®Google Scholar
• Loken M.R., Shah V.O., Dattilio K.L., Civin C.I. Flow cytornetric analysis of human bone marrow 11. Normal B lymphocyte development. Blood 1987; 70: 1316–1324
   PubMed Web of Science ®Google Scholar
• Lansdorp P.M., Sutherland H.J., Eaves C.J. Selective expression of CD45 isoforms on functional subpopulations of CD34+ hematopoietic cells from human bone marrow. Journal of Experimental Medicine 1990; 172: 363–366
   PubMed Web of Science ®Google Scholar
• Lansdorp P.M., Dougherty G.J., Humphries R.K. CD34 epitopes. Leukocyte typing IV, white cell differentiation antigens, W. Knapp, B. Dörken, W.R. Gilkes, E.P. Reiber, R.E. Schmidt, H. Stein, A. E. G. Kr. von dem Borne. Oxford Univ Press, OxfordEngland 1989; 826
   Google Scholar
• Andrews R.G., Singer J.W., Bernstcin I.D. Monoclonal antibody 12.8 recognizes a 115 kD molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 1986; 67: 842–845
   PubMed Web of Science ®Google Scholar
• Civin C.I., Strauss L.C., Brovall C., Facker J.F., Schwartz J.F., Shaper J.H. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-la cells. Journal of Immunology 1984; 133: 157–165
   PubMed Web of Science ®Google Scholar
• Beschorner W.E., Civin C.I., Strauss L.C. Localization of hematopoietic progenitor cells in tissue with the anti-My-10 monoclonal antibody. American Journal of Pathology 1985; 119: 1–4
   PubMed Web of Science ®Google Scholar
• Terstappen L. W. M. M., Huang S., Safford M., Lansdorp P.M., Loken P.M. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. Blood 1991; 77: 1218–1227
   PubMed Web of Science ®Google Scholar
• Bemstein I.D., Andrews R.G., Zsebo K.M. Recombinant human stem cell factor enhances the formation of colonies by the CD34+lin- cells and the generation of colony-forming cell progeny from CD34+lin- cells cultured with interleukin-3, granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor. Blood 1991; 77: 2316–2321
   PubMed Web of Science ®Google Scholar
• Dehili N., Issaad C., Masse J.-M., Guichard J., Katz A., Breton-Gorius J., Vainchenker W. Expression of CD34 and platelet glycoprotein during human megakaryocytic differentiation. Blood 1992; 80: 3022–3035
   PubMed Web of Science ®Google Scholar
• Geller R.B., Zahurak M., Hurwitz C.A., Burke P.J., Karp J.E., Piantadosi S., Civin C.I. Prognostic importance of immunophenotyping in adults with acute myelocytic leukemia: the significance of the stem-cell glycoprotein CD34 (MY10). British Journal of Haematology 1990; 76: 340–347
   PubMed Web of Science ®Google Scholar
• Terstappen L.W., Safford M., Unterhalt M., Konemann S., Zurlutter K., Piechotka K., Drescher M., Aul C., Buchner T., Hiddemann W. Flowcytometric characterization of acute myeloid leukemia: IV. Comparison to the differentiation pathway of normal hematopoietic progenitor cells. Leukemia 1992; 6: 993–1000
   PubMed Web of Science ®Google Scholar
• Campos L., Guyotat D., Archimbaud E., Calmard-Oriol P., Tsuruo T., Troncy J., Treille D., Fiere D. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia at diagnosis. Blood 1992; 79: 473–476
   PubMed Web of Science ®Google Scholar
• Guinot M., Sanz G.F., Sempere A., Arilla M.J., Jarque I., Gomis F., Sanz M.A. Prognostic value of CD34 expression in de novo acute myeloblastic leukemia. British Journal of Haematology 1991; 79: 533–534
   PubMed Web of Science ®Google Scholar
• Campos L., Guyotat D., Archimbaud E., Devaux Y., Treille D., Larese A., Maupas J., Gentilhomme O., Ehrsam A., Fiere D. Surface marker expression in adult acute myeloid leukemia: correlations with initial characteristics, morphology and response to therapy. British Jonrnal of Haematology 1989; 72: 161–6
   PubMed Web of Science ®Google Scholar
• Borowitz M.J., Gockeman J.P., Moore J.O., Civin C.I., Page S.O., Robertson J., Bigner S.H. Clinicopathologic and cytogenetic features of CD34 (My 10)-positive acute nonlymphocytic leukemia. American Journal of Clinical Pathology 1989; 91: 265–70
   PubMed Web of Science ®Google Scholar
• Lee E.J., Yang J., Leavitt R.D., Testa J.R., Civin C.I., Forrest A., Schiffer C.A. The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia. Leukemia 1992; 6: 1203–1209
   PubMed Web of Science ®Google Scholar
• Solary E., Casasnovas R.O., Campos L., Bene M.C., Faure G., Maingon P., Falkenrodt A., Lenormand B., Genetet N. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD 14+/DR—phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucemies (GEIL). Leukemia 1992; 6: 393–399
   PubMed Web of Science ®Google Scholar
• Te Boekhorst P. A. W., de Leeuw K., Schoester M., Wittebol S., Nooter K., Hagemeijer A., Lowenherg B., Sonneveld P. Predominance of functional multidrug resistance (MDRI) phenotype in CD34+ acute myeloid leukemia cells. Blood 1993; 82: 3157–3162
   PubMed Web of Science ®Google Scholar
• Selleri C., Notaro R., Catalano L., Fontana R., del Vecchio L., Rotoli B. Prognostic irrelevance of CD34 in acute myeloid leukemia. British Journal of Haematology 1992; 82: 479–482
   PubMed Web of Science ®Google Scholar
• Ciolli S., Leoni F., Caporale R. CD34 Expression fails to predict the outcome in adult acute myeloid leukemia. Hematologica 1993; 78: 151–155
   PubMed Web of Science ®Google Scholar
• Sperling C., Buchner T., Sauerland C., Fonatsch C., Thiel E., Ludwig W.D. CD34 expression in de novo acute myeloid leukaemia. Br J Haematol 1993; 85: 635–637
   PubMed Web of Science ®Google Scholar
• Davey F.R., Nelson D.A. Periodic acid Schiff stain. Hematology2nd ed., W.J. Williams, E. Beutler, A.J. Erslev, R.W. Rundles. McGraw Hill, New York 1977; 1630–1632
   Google Scholar
• Yam L.T., Li C.Y., Crosby W.H. Cytochemical identification of monocytes and granulocytes. American Journal oj Cliniccil Puthology 1971; 55: 283–288
   PubMed Web of Science ®Google Scholar
• Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D. A. G., Ciralnick H.R., Sultan C. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). Annals of Internal Medicine 1985a; 108: 460–462
   Google Scholar
• Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D. A. G., Gralnick H.R., Sultan C. Proposed revised criteria for the classification of acute myelogenous leukemia. Annals of Internal Medicine 1985; 103: 626–629
   PubMedGoogle Scholar
• Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D. A. G., Gralnick H.R., Sultan C. Proposal for the recognition of minimally differentiated acute myelogenous leukemia (AML-MO). British Journal of Haematology 1991; 78: 325–329
   PubMed Web of Science ®Google Scholar
• ISCN. Guidelines for cancer cytogentics Supplement to an International System for Human Cytogenetic Nomenclarure, F. Mitelman. S. Karger, Basel 1991
   Google Scholar
• Cheson B.D., Cassileth P.A., Head D.R., Schiffer C.A., Bennett J.M., Bloornfield C.D., Brunning R., Gale R.P., Grever M.R., Keating M.J., Sawitsky A., Stass S., Weinstein H., Woods W.G. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myelogenous leukemia. Jorunal of Clinical Oncology 1990; 8: 813–819
   PubMed Web of Science ®Google Scholar
• Askew D.S., Eaves A.C., Takei F. NHL-30.5: a monoclonal antibody reactive with an acute myeloid leukemia (AML)-associated antigen. Leukemia Research 1985; 9: 135–145
   PubMed Web of Science ®Google Scholar
• Shepherd J.D., Reece D.E., Barnett M.J., Klingemann H.G., Nantel S.H., Sutherland H.J., Philips G.L. Induction therapy for acute myelogenous leukemia in patients over 60 years with intermediate-dose cytosine arabinoside, mitoxantrone and etoposide. Leukemia & Lymphoma 1993; 9: 211–215
   PubMed Web of Science ®Google Scholar
• Shepherd J.D., Reece D.E., Barnett M.J., Nantel S.H., Klingemann H.-G., Sutherland H.J., Spinelli J.J., Phillips G.L. Induction chemotherapy with continuous infusion ara-c, mitoxantrone, and VP-16 for patients less than 65 years old with acute myeloid leukemia. Proceedings of American Society of Clinical Oncology 1994; 13: 308, 1994
   Google Scholar
• Conover W.J. Practical Nonparametric Statistics2nd Ed. John Wiley & Sons, New York 1980; 229–239
   Google Scholar
• Sutherland D.R., Marsh J.C., Davidson J., Baker M.A., Keating A., Mellors A. Differential sensitivity of CD34 epitopes to cleavage by Pasteurella haemolytica glycoprotease: implications for purification of CD34-positive progenitor cells. Experimenral Hematology 1992; 20: 590–599
   PubMed Web of Science ®Google Scholar
• Hanson C.A., Ross C.W., Schnitzer B. Anti-CD34 immunoperoxidase staining in paraffin section of acute leukemia: Comparison with tlow cytometric immunophenotyping. American Journal of Clinical Pathology 1992; 23: 26–32
   Google Scholar
• Siena S., Bregni M., Brando B., Belli N., Lansdorp P.M., Bonadonna G., Gianni M. Flow cytometry to estimate circulating hematopoietic progenitors for autologous bone marrow transplantation comparative analysis of different CD34 monoclonal antibodies. Haematologica 1991; 76: 330–333
   PubMed Web of Science ®Google Scholar
• Smith B.R. Qualitative versus quantitative immunophenotyping. Annals of the New York Academy of Sciences 1993; 677: 152–154
   PubMed Web of Science ®Google Scholar
• Udomsakdi C., Eaves C.J., Sutherland H.J., Lansdorp P.M. Separation of functionally distinct subpopulalions of primitive human hematopoietic cells using rhodamine-123. Experimental Haematology 1991; 19: 338–342
   PubMed Web of Science ®Google Scholar
• Bernstein I.D., Singer J.W., Smith F.O., Andrews R.G., Flowers D.A., Petersens J., Steinmann L., Najfeld V., Savage D., Fruchtman S., Arlin Z., Fialkow P.J. Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia. Blood 1992; 79: 1811–1816
   PubMed Web of Science ®Google Scholar